Dersimelagon in Erythropoietic Protoporphyrias
New England Journal of Medicine · 2023
DOI: 10.1056/nejmoa2208754 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, 2023. Verfasst von Manisha Balwani und 9 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York (M.B., R.J.D.); the Section on Gastroenterolo…. Hauptthemen laut MEDLINE: Photosensitivity Disorders, Receptor, Melanocortin, Type 1, Protoporphyria, Erythropoietic, Dermatologic Agents. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Mitsubishi Tanabe Pharma Group.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York (M.B., R.J.D.); the Section on Gastroenterology and Hepatology, Wake Forest University-North Carolina Baptist Medic…
Förderung
- Mitsubishi Tanabe Pharma Group
Zitieren
APA
Balwani, M., Bonkovsky, H. L., Levy, C., Anderson, K. E., Bissell, D. M., Parker, C., Takahashi, F., Desnick, R. J., Belongie, K., & Endeavor Investigators (2023). Dersimelagon in Erythropoietic Protoporphyrias. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2208754
Vancouver
Balwani M, Bonkovsky HL, Levy C, Anderson KE, Bissell DM, Parker C, et al. Dersimelagon in Erythropoietic Protoporphyrias. New England Journal of Medicine. 2023. doi:10.1056/nejmoa2208754
BibTeX
@article{Balwani2023,
author = {Balwani, Manisha and Bonkovsky, Herbert L and Levy, Cynthia and Anderson, Karl E and Bissell, D Montgomery and Parker, Charles and Takahashi, Fumihiro and Desnick, Robert J and Belongie, Kirstine and Endeavor Investigators, Endeavor Investigators},
title = {Dersimelagon in Erythropoietic Protoporphyrias},
journal = {New England Journal of Medicine},
year = {2023},
doi = {10.1056/nejmoa2208754}
}
EUVIMED